Evidence map›Paper›PMID 32793353›Full record

ArticleNew microbes and new infections2020

S Konate, C I Lo, E Kuete, M Sarr, N Amsrtong, A Levasseur, A Caputo, M A Thera, D Raoult, M Million

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Halobacillus as source of natural products and enzyme factories.Extremophiles : life under extreme conditions · 2025
    Review
  2. Review
  3. Review
  4. Draft genome sequence ofMicrobiology resource announcements · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

S KonateAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
C I LoIHU-Méditerranée Infection, Marseille, France.
E KueteAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
M SarrAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
N AmsrtongAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
A LevasseurAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
A CaputoAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
M A TheraAix Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.
D RaoultAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
M MillionAix Marseille Université, IRD, AP-HM, MEФI, Marseille, France.
Institut de Recherche pour le Développement · FRMéditerranée Infection Foundation · FRAix-Marseille Université · FRUniversity of Bamako · ML

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strain Marseille-Q1234

Indexed as

CulturomicsHalobacillus ihumiisp. nov.human microbiotamalitaxonogenomics

Identifiers

PMID32793353
PMCPMC7408719
OpenAlexW3034089179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.